- Home
- Equipment
- usa massachusetts
- digestate
Show results for
Refine by
Applications
- Microbiome Therapeutics for Patients and Physicians
- Duodenal Mucosal Resurfacing System (DMR) for Type 2 Diabetes
- Duodenal Mucosal Resurfacing System (DMR) for Clinical Research Studies
- Duodenal Mucosal Resurfacing System (DMR) for T2Di Study
- Duodenal Mucosal Resurfacing System (DMR) for Healthcare Professionals
Digestate Equipment Supplied In Usa Massachusetts
11 equipment items found
Manufactured by:Genovis Group based inKävlinge, SWEDEN
GlySERIAS Lyophilized is available as a lyophilized powder in 2000 unit vials for digestion of 2 mg fusion ...
Manufactured by:Peters Surgical based inBoulogne-Billancourt, FRANCE
Simple gesture: no handling of a suture (thread+ straight needle) inside the abdominal cavity. Release one hand of an operator holding a grasping forceps : operating time saving. Minimized risks of digestive or vascular wounds (vs straight needle/suture). Mini invasive abdominal wall perforation (no additional trocar incision). Reduced degree of Trendelenburg position for the ...
Manufactured by:Peters Surgical based inBoulogne-Billancourt, FRANCE
Simple gesture: no handling of a suture (thread+ straight needle) inside the abdominal cavity. Release one hand of an operator holding a grasping forceps : operating time saving. Minimized risks of digestive or vascular wounds (vs straight needle/suture). Mini invasive abdominal wall perforation (no additional trocar incision). Reduced degree of Trendelenburg position for the ...
Manufactured by:Isto Biologics based inHopkinton, MASSACHUSETTS (USA)
InQu® is the cell-friendly biosynthetic™ bone graft with proven clinical efficacy leading to faster bone ...
Manufactured by:Seres Therapeutics, Inc. based inCambridge, MASSACHUSETTS (USA)
SER-301 is an investigational, oral, rationally-designed, fermented microbiome therapeutic for the treatment of mild-to-moderate ulcerative colitis (UC). SER-301 is a consortium of multiple bacterial strains that is manufactured by fermenting each strain individually and then combining to form drug product. ...
Manufactured by:Seres Therapeutics, Inc. based inCambridge, MASSACHUSETTS (USA)
SER-287 is an investigational, oral, biologically-derived microbiome therapeutic for the treatment of ulcerative colitis (UC). SER-287 is a consortium of multiple bacterial spores manufactured by fractionating and purifying targeted bacteria from stool of healthy human donors. SER-287 has been granted Fast Track designation and Orphan Drug designation by the FDA. A completed SER-287 Phase 1b ...
by:Harvard Apparatus Regenerative Technology, Inc. formely known as Biostage, Inc. based inHolliston, MASSACHUSETTS (USA)
Cellspan Esophageal Implants may offer improved outcomes for patients by potentially simplifying surgical techniques to reduce post-operative complications, improve quality of life and enable regeneration of the patient’s own ...
Manufactured by:Emulate based inBoston, MASSACHUSETTS (USA)
Study drug absorption and drug-drug interactions in a primary organoid-based model of the human small ...
Manufactured by:Axial Therapeutics Inc. based inWoburn, MASSACHUSETTS (USA)
Addressing Unmet Medical Needs in Autism Spectrum Disorder. According to the Centers for Disease Control and Prevention (CDC), approximately 1 in 54 children has been identified with Autism Spectrum Disorder (ASD). Core symptoms of ASD include impairments in social interaction, communication, and the presence of stereotyped repetitive behaviors. Co-occurring conditions that impact quality of life ...
by:Vertex Pharmaceuticals based inBoston, MASSACHUSETTS (USA)
Cystic fibrosis (CF) is a rare, chronic and life-shortening genetic disease. It’s a progressive, multi-system disease that affects the lungs, liver, gastrointestinal tract, pancreas, sinuses, sweat glands and reproductive tract. In the lungs, this leads to the buildup of abnormally thick, sticky mucus that can cause chronic lung infections and inflammation, resulting in progressive lung ...
Manufactured by:Fractyl Health based inLexington, MASSACHUSETTS (USA)
Our lead product candidate, the Revita DMR System, or Revita®, is a first-in-class procedural therapy designed to target the duodenum as a root cause of type 2 diabetes. For people with advanced type 2 diabetes, the main form of therapy to control HbA1c today is insulin dose escalation and lifestyle interventions. We have developed and are investigating Revita DMR with the goal of providing ...